Advances in Drug Formulation Technology: Enhancing Bioavailability and Patient Compliance
Main Article Content
Abstract
Drug formulation technology is continuously evolving to improve the efficacy and patient experience of pharmaceuticals. This paper explores recent advancements in drug formulation techniques aimed at enhancing drug bioavailability and promoting patient compliance. By addressing challenges related to drug solubility, stability, and delivery, these innovations have the potential to revolutionize drug development and patient care. This paper provides an overview of these advancements, their mechanisms, and their impact on the pharmaceutical industry and healthcare.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
Aldeer, M., Tawalbeh, L. I., et al. (2020). Impact of mobile health applications on patients' adherence to medication, disease control, and clinical outcomes: A meta-analysis. Journal of Medical Internet Research, 22(4), e15672.
Amidon, G. L., Lennernäs, H., & Shah, V. P. (1995). Criseof dissolunoted states of poorly soluble drugs. Pharmaceutical Research, 12(3), 413-420.
Anderson, J. M., & Shive, M. S. (2012). Biodegradation and biocompatibility of PLA and PLGA microspheres. Advanced Drug Delivery Reviews, 64(1), 72-82.
Anderson, R. E., & Truscott, R. J. (2017). Antioxidant science and the foundations of a new health model. Free Radical Biology and Medicine, 108, 201-207.
Brown, R. S., & Burden, F. R. (2016). Pharmaceuticals, personal care products and endocrine disrupting agents: implications for the environment. Annual Reports in Computational Chemistry, 12, 1-44.
Chaudhari, S. R., Dugar, R. P., et al. (2020). Artificial intelligence and machine learning in pharmaceutical formulation development. Expert Opinion on Drug Development, 17(4), 437-449.
Constable, D. J., Dunn, P. J., et al. (2020). Key green chemistry research areas—A perspective from pharmaceutical manufacturers. Green Chemistry, 22(6), 1861-1886.
Davis, M. E., Chen, Z. G., & Shin, D. M. (2008). Nanoparticle therapeutics: an emerging treatment modality for cancer. Nature Reviews Drug Discovery, 7(9), 771-782.
Farokhzad, O. C., & Langer, R. (2014). Impact of nanotechnology on drug delivery. ACS Nano, 3(1), 16-20.
Mulla Shamshad, Q.N.Qhuddsia (2023). Eficacy of Munzij Mushil and Zimaad Therapy in Sala E Sadi
(Fibroadenoma of Breast) - A Randomized Single-Blind Study. Acta Traditional Medicine. V2i01, 43-
DOI: https://doi.org/10.51470/ATM.2023.2.1.43
Food and Drug Administration. (2020). Advancing Health through Innovation: New Drug Therapy Approvals 2019. U.S. Department of Health and Human Services.
Hamburg, M. A., & Collins, F. S. (2010). The path to personalized medicine. New England Journal of Medicine, 363(4), 301-304.
Ashiq Hussain, Mohd Ishaq, Aniketa Sharma (2023). Utility and feasibility of Phosphodiesterase inhibitors in the treatment COVID-19 patients. Acta Traditional Medicine. V2i01, 50-53. DOI: https://doi.org/10.51470/ATM.2023.2.1.50
International Council for Harmonisation (ICH). (2003). ICH Harmonised Tripartite Guideline: Stability Testing of New Drug Substances and Products (Q1A(R2)).
Johnson, A. L. (2018). Patient-centric drug formulations: Current perspectives and future directions. Drug Development and Industrial Pharmacy, 44(7), 1081-1086.
Lavorini, F. (2019). Inhaled drug delivery in the hands of the patient. Journal of Aerosol Medicine and Pulmonary Drug Delivery, 32(3), 143-147.
Lee, C. H., & Kim, J. H. (2018). Microencapsulation methods for delivery of drugs and nutrients. Archives of Pharmacal Research, 41(10), 958-965.
Lee, S. H., & Park, T. G. (2021). Controlled drug delivery systems: Past forward and future back. Journal of Controlled Release, 330, 662-676.
Liu, Y., Chang, C., et al. (2019). Strategies for formulation development of poorly water-soluble drugs with increased oral bioavailability. International Journal of Pharmaceutics, 570, 118642.
Kahkashan Parvin, Aparna Srivastava, Narmada Hidangmayum, Swarnika Bansal, Rose Meher, Radhika Awasthi (2023). Exploring the Evolving Role of Herbal and Alternative Medicine in Modern Healthcare. Acta Traditional Medicine. V2i01 35-42. DOI: https://doi.org/10.5281/zenodo.8357773
Loftsson, T., Jarho, P., & Másson, M. (2007). Cyclodextrins in drug delivery. Expert Opinion on Drug Delivery, 4(2), 139-152.
Lu, Y., Wu, H., et al. (2019). Antioxidants in pharmaceutical formulations: Key factors for shelf-life extension. Molecules, 24(1), 191.
Moes, D. J., Guchelaar, H. J., & de Kam, M. L. (2019). The role of pharmacogenetics in the disposition of and response to antipsychotic drugs. CNS Drugs, 33(6), 533-553.
Pardi, N., Hogan, M. J., et al. (2018). mRNA vaccines—a new era in vaccinology. Nature Reviews Drug Discovery, 17(4), 261-279.
Patel, M. R., & Patel, R. B. (2020). A comprehensive review on pH modulation for drug delivery. Critical Reviews in Therapeutic Drug Carrier Systems, 37(2), 111-142.
Patel, N. K. (2016). Excipients in pharmaceuticals: A review. International Journal of Pharma and Bio Sciences, 7(3), 17-31.
Porter, C. J., Trevaskis, N. L., & Charman, W. N. (2007). Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs. Nature Reviews Drug Discovery, 6(3), 231-248.
Prausnitz, M. R., & Langer, R. (2008). Transdermal drug delivery. Nature Biotechnology, 26(11), 1261-1268.
Rao, S. S., & Parthasarathy, P. (2019). Oral disintegrating tablets: An overview. Journal of Pharmaceutical Sciences and Research, 11(11), 3039-3046.
Rey, L., Quintanar, D., & Tapia, M. (2015). Aqueous polymeric coatings for pharmaceutical dosage forms. Drug Development and Industrial Pharmacy, 41(2), 359-373.
Robinson, J. R., & Lee, V. H. (1987). Controlled drug delivery: Fundamentals and applications. CRC Press.
Rowe, R. C., Sheskey, P. J., & Quinn, M. E. (Eds.). (2017). Handbook of pharmaceutical excipients. Pharmaceutical Press.
Essra Ali Safdar, Nida Ali Safdar, Syeda Aifa Fathima, Pathan Amanullah Khan (2023). A Survey to Assess Knowledge Attitude Practice of People towards Vitamin D. Acta Traditional Medicine. V2i01, 27-34. DOI: https://doi.org/10.5281/zenodo.8282626
Sadia, M., Sośnicka, A., et al. (2019). 3D Printing in Pharmaceutical and Medical Applications: Recent Achievements and Challenges. Pharmaceutics, 11(4), 159.
Sarker, D. K., Engineering of nanoemulsions for drug delivery. (2017). Journal of Biomaterials and Nanobiotechnology, 8(3), 198-216.
Serajuddin, A. T., Sheen, P. C., & Augustine, M. A. (1999). Improved oral bioavailability of a poorly watersoluble drug, RS-8359, in dogs, based on a ternary solid dispersion with PEG 6000 and TPGS. Journal of Pharmaceutical Sciences, 88(9), 968-972.
Sharma, S., & Thakur, S. K. (2019). Drug stability and shelf life under ambient conditions: Recent developments and regulatory updates. Drug Development and Industrial Pharmacy, 45(6), 839-853.
Singh, P., Sah, V. R., & Kumar, A. (2019). Blister packaging: A review. Journal of Pharmaceutical Research International, 27(5), 1-12.
Smith, J. K. (2020). Injectable drug delivery: Recent advances. Journal of Pharmaceutical Sciences, 109(3), 1215-1225.
Smith, J. K., & Johnson, A. L. (2019). Regulatory compliance in pharmaceutical manufacturing. In G. L. Amidon, H. Lennernäs, & V. P. Shah (Eds.), Pharmaceutical Quality by Design: A Practical Approach (pp. 181-201). CRC Press.
Smith, J. M., Patel, D. S., & Johnson, A. L. (2021). Innovations in pharmaceutical packaging for extended shelf life. Drug Development and Industrial Pharmacy, 47(2), 187-194.
Stella, V. J., Nti-Addae, K. W., & Prodrug strategies to overcome poor water solubility. (2007). Advanced Drug Delivery Reviews, 59(7), 677-694.
Sun, B., Yeo, Y., & Nanoparticle-Based Medicines: A Review. (2012). Drug Delivery and Translational Research, 2(6), 503-514.
United States Pharmacopeia. (2020). United States Pharmacopeia (USP) Chapter <905> Uniformity of Dosage Units. USP 43-NF 38.
Williams, H. D., Trevaskis, N. L., et al. (2018). Strategies to address low drug solubility in discovery and development. Pharmacological Reviews, 70(3), 413-463.
Yan, Y. D., Weon, K. Y., & Park, C. S. (2020). Advances in biopharmaceutical properties of poorly watersoluble drugs and the impacts of biopharmaceutics classification system. Journal of Pharmaceutical Investigation, 50(5), 481-492.